# An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)

> **NCT01417377** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 22 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Mircera

## Key facts

- **NCT ID:** NCT01417377
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-31
- **Primary completion:** 2012-03-31
- **Final completion:** 2012-03-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417377, "An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01417377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*